These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 30844117

  • 1. Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal squamous cell carcinoma.
    Shen LY, Zhou T, Du YB, Shi Q, Chen KN.
    Cancer Sci; 2019 May; 110(5):1735-1745. PubMed ID: 30844117
    [Abstract] [Full Text] [Related]

  • 2. HOXB7 mediates cisplatin resistance in esophageal squamous cell carcinoma through involvement of DNA damage repair.
    Zhou T, Fu H, Dong B, Dai L, Yang Y, Yan W, Shen L.
    Thorac Cancer; 2020 Nov; 11(11):3071-3085. PubMed ID: 31568655
    [Abstract] [Full Text] [Related]

  • 3. Targeting the HOX/PBX dimer in breast cancer.
    Morgan R, Boxall A, Harrington KJ, Simpson GR, Gillett C, Michael A, Pandha HS.
    Breast Cancer Res Treat; 2012 Nov; 136(2):389-98. PubMed ID: 23053648
    [Abstract] [Full Text] [Related]

  • 4. HOX transcription factors are potential targets and markers in malignant mesothelioma.
    Morgan R, Simpson G, Gray S, Gillett C, Tabi Z, Spicer J, Harrington KJ, Pandha HS.
    BMC Cancer; 2016 Feb 11; 16():85. PubMed ID: 26867567
    [Abstract] [Full Text] [Related]

  • 5. Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes.
    Platais C, Radhakrishnan R, Niklander Ebensperger S, Morgan R, Lambert DW, Hunter KD.
    BMC Cancer; 2018 Jul 06; 18(1):723. PubMed ID: 29980182
    [Abstract] [Full Text] [Related]

  • 6. Targeting HOX transcription factors in prostate cancer.
    Morgan R, Boxall A, Harrington KJ, Simpson GR, Michael A, Pandha HS.
    BMC Urol; 2014 Feb 05; 14():17. PubMed ID: 24499138
    [Abstract] [Full Text] [Related]

  • 7. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
    Zhang J, Liu S, Zhang D, Ma Z, Sun L.
    J Cell Biochem; 2019 Aug 05; 120(8):13717-13725. PubMed ID: 30938888
    [Abstract] [Full Text] [Related]

  • 8. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
    Jiang YY, Jiang Y, Li CQ, Zhang Y, Dakle P, Kaur H, Deng JW, Lin RY, Han L, Xie JJ, Yan Y, Doan N, Zheng Y, Mayakonda A, Hazawa M, Xu L, Li Y, Aswad L, Jeitany M, Kanojia D, Guan XY, Said JW, Yang W, Fullwood MJ, Lin DC, Koeffler HP.
    Gastroenterology; 2020 Oct 05; 159(4):1311-1327.e19. PubMed ID: 32619460
    [Abstract] [Full Text] [Related]

  • 9. Targeting HOX/PBX dimers in cancer.
    Morgan R, El-Tanani M, Hunter KD, Harrington KJ, Pandha HS.
    Oncotarget; 2017 May 09; 8(19):32322-32331. PubMed ID: 28423659
    [Abstract] [Full Text] [Related]

  • 10. Novel carbazole sulfonamide microtubule-destabilizing agents exert potent antitumor activity against esophageal squamous cell carcinoma.
    Niu F, Liu Y, Jing Z, Han G, Sun L, Yan L, Zhou L, Wu Y, Xu Y, Hu L, Zhao X.
    Cancer Lett; 2018 Apr 28; 420():60-71. PubMed ID: 29408653
    [Abstract] [Full Text] [Related]

  • 11. Mechanism investigation of Forsythoside A against esophageal squamous cell carcinoma in vitro and in vivo.
    Yang Y, Shen J, Deng P, Chen P.
    Cancer Biol Ther; 2024 Dec 31; 25(1):2380023. PubMed ID: 39046082
    [Abstract] [Full Text] [Related]

  • 12. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
    Bolidong D, Domoto T, Uehara M, Sabit H, Okumura T, Endo Y, Nakada M, Ninomiya I, Miyashita T, Wong RW, Minamoto T.
    Sci Rep; 2020 Jul 16; 10(1):11807. PubMed ID: 32678196
    [Abstract] [Full Text] [Related]

  • 13. Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity.
    Zhang W, Yan W, Qian N, Han Q, Zhang W, Dai G.
    Chin Med J (Engl); 2022 Feb 21; 135(5):606-618. PubMed ID: 35191417
    [Abstract] [Full Text] [Related]

  • 14. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW, Jia YX, Zhang WJ, Song LJ, Gao M, Li MJ, Zhao RH, Li J, Zhong YL, Sun QZ, Qin YR.
    J Exp Clin Cancer Res; 2018 Mar 12; 37(1):56. PubMed ID: 29530057
    [Abstract] [Full Text] [Related]

  • 15. The anti-tumor activity of tangeretin in esophageal squamous cell carcinoma by inhibiting GLI2-mediated transcription of GPNMB.
    Yang D, Zhang Q, Kuang H, Liu J, Wu S, Wei L, Yao W.
    PLoS One; 2024 Mar 12; 19(6):e0291531. PubMed ID: 38924029
    [Abstract] [Full Text] [Related]

  • 16. Long noncoding RNA PANDA promotes esophageal squamous carcinoma cell progress by dissociating from NF-YA but interact with SAFA.
    Shi W, Wang Q, Bian Y, Fan Y, Zhou Y, Feng T, Li Z, Cao X.
    Pathol Res Pract; 2019 Oct 12; 215(10):152604. PubMed ID: 31495606
    [Abstract] [Full Text] [Related]

  • 17. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
    Sugase T, Takahashi T, Serada S, Nakatsuka R, Fujimoto M, Ohkawara T, Hara H, Nishigaki T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Kishimoto T, Mori M, Doki Y, Naka T.
    Int J Cancer; 2017 Jun 01; 140(11):2608-2621. PubMed ID: 28233302
    [Abstract] [Full Text] [Related]

  • 18. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
    Liu Y, Zhi Y, Song H, Zong M, Yi J, Mao G, Chen L, Huang G.
    J Exp Clin Cancer Res; 2019 Aug 22; 38(1):369. PubMed ID: 31438989
    [Abstract] [Full Text] [Related]

  • 19. Targeting HOX and PBX transcription factors in ovarian cancer.
    Morgan R, Plowright L, Harrington KJ, Michael A, Pandha HS.
    BMC Cancer; 2010 Mar 10; 10():89. PubMed ID: 20219106
    [Abstract] [Full Text] [Related]

  • 20. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
    Zhong YB, Shan AJ, Lv W, Wang J, Xu JZ.
    Eur Rev Med Pharmacol Sci; 2018 Dec 10; 22(23):8288-8297. PubMed ID: 30556869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.